EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

The clinical value of metagenomic next generation sequencing in the diagnosis of non-neutropenic invasive pulmonary aspergillosis

Huanhuan Zhong, Chao Sun, Yajie Lu, Xiaomin Cai, Min Cao, Li Wang, Chunlai Feng, Mengyue Song, Wenkui Sun, Minhua Shi, Yujian Tao, Jun Zhou und 11 weitere

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2026.1731736 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Huanhuan Zhong und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanj…. Hauptthemen laut MEDLINE: Invasive Pulmonary Aspergillosis, High-Throughput Nucleotide Sequencing, Metagenomics, Aspergillus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aims to explore the performance of metagenomic next generation sequencing (mNGS) in the diagnosis of non-neutropenic invasive pulmonary aspergillosis (IPA) and its clinical application value.

Methods

This multi-center study enrolled 293 suspected IPA patients who conducted mNGS from October 2020 to February 2024. These cases were classified into IPA group and non-IPA group according to IPA diagnostic criteria. We analyzed the diagnostic value of mNGS by comparing with sputum culture, BALF culture, serum and BALF GM test.

Results

A total of 118 IPA patients (4 proven/113 probable/1 possible diagnosis) were included in our study. The most common Aspergillus species was A. fumigatus (63.4%), followed by A. flavus (23.2%), A. oryzae (7.1%), A. niger (3.6%) and A. terreus (2.7%). The sensitivity of bronchoalveolar lavage fluid (BALF) mNGS was significantly higher than BALF culture (81.9% vs. 27.0%, p<0.001) and BALF galactomannan (GM) (81.9% vs. 55.8% (GM≥1.0 cutoff value), p<0.001). The specificity of BALF mNGS was 92.2%, which was similar with BALF culture (98.5%) and BALF GM (94.7%). The combination of BALF mNGS and GM could increase the sensitivity to 88.7%, and had great negative predictive value (NPV, 92.3%). The sensitivity of blood mNGS was significantly higher than serum GM (58.8% vs. 16.7%, p<0.001). And the sensitivity of sputum mNGS was 66.7%, which was significantly higher than sputum culture (30.0%, p=0.025). Conclusion mNGS demonstrated significant diagnostic value for IPA, exhibiting significantly higher sensitivity compared to current conventional microbiological tests while maintaining equivalent specificity. The combination of BALF mNGS with GM performed great sensitivity and negative predictive value. BALF specimens seemed to be superior to blood and sputum samples. However, for patients unable to undergo bronchoscopy, sputum and blood mNGS were still superior to other methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Invasive Pulmonary AspergillosisHigh-Throughput Nucleotide SequencingMetagenomicsAspergillusHumansBronchoalveolar Lavage FluidFemaleSputumMaleSensitivity and SpecificityMiddle AgedAdultGalactoseAgedMannans

Stichwörter der Autor:innen

diagnostic valueinvasive pulmonary aspergillosismetagenomic next generation sequencingmicrobiological testnon-neutropenic

Substanzen

GalactosegalactomannanMannans

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
  • Department of Respiratory and Critical Care Medicine, Nanjing Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Department of Respiratory and Critical Care Medicine, Jiangsu Second Chinese Medicine Hospital, Nanjing, China.
  • Department of Respiratory and Critical Care Medicine, Nanjing First Hospital, Nanjing, China.
  • Department of Respiratory and Critical Care Medicine, Changzhou First People's Hospital, Changzhou, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhong, H., Sun, C., Lu, Y., Cai, X., Cao, M., Wang, L., Feng, C., Song, M., Sun, W., Shi, M., Tao, Y., Zhou, J., Chen, C., Lu, X., Li, Y., Ni, Y., Cai, Y., Zhong, J., Li, Y., …, & Su, X. (2026). The clinical value of metagenomic next generation sequencing in the diagnosis of non-neutropenic invasive pulmonary aspergillosis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1731736

Vancouver

Zhong H, Sun C, Lu Y, Cai X, Cao M, Wang L, et al. The clinical value of metagenomic next generation sequencing in the diagnosis of non-neutropenic invasive pulmonary aspergillosis. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1731736

BibTeX
@article{Zhong2026,
  author = {Zhong, Huanhuan and Sun, Chao and Lu, Yajie and Cai, Xiaomin and Cao, Min and Wang, Li and Feng, Chunlai and Song, Mengyue and Sun, Wenkui and Shi, Minhua and Tao, Yujian and Zhou, Jun and Chen, Cheng and Lu, Xin and Li, Yuanqin and Ni, Yueyan and Cai, Yuchen and Zhong, Jinjin and Li, Yuanyuan and Wu, Weiwei and Shi, Yi and Wang, Min and Su, Xin},
  title = {The clinical value of metagenomic next generation sequencing in the diagnosis of non-neutropenic invasive pulmonary aspergillosis},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2026.1731736}
}
Kostenlos starten →